54232-43-8

Basic information

• Product Name: 6-BROMO-5-METHOXY-2-PYRIDINECARBOXYLIC ACID
• Synonyms: 6-BROMO-5-METHOXY-2-PYRIDINECARBOXYLIC ACID;6-BROMO-5-METHOXYPICOLINIC ACID;2-Bromo-3-methoxypyridine-6-carboxylic acid;6-bromo-5-methoxypyridine-2-carboxylic acid;6-Bromo-5-methoxy-2-pyridinecarboxylic acid ,97%;6-Bromo-5-Methoxy-2-Pyridinecarboxylic Acid 6-Bromo-5-Methoxy-2-Pyridinecarboxylic Acid ,97%
• CAS NO: 54232-43-8
• Molecular Formula: C₇H₆BrNO₃
• Molecular Weight: 232.03
• EINECS: 200-589-5
• Product Categories: Pyridine series;Carboxylic Acids;Pyridines;Carboxylic Acids
• Mol File: 54232-43-8.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 362.8 °C at 760 mmHg
• Flash Point: 173.2 °C
• Appearance: /
• Density: 1.713 g/cm³
• Vapor Pressure: 6.73E-06mmHg at 25°C
• Refractive Index: 1.589
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 3.52±0.10(Predicted)
• CAS DataBase Reference: 6-BROMO-5-METHOXY-2-PYRIDINECARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BROMO-5-METHOXY-2-PYRIDINECARBOXYLIC ACID(54232-43-8)
• EPA Substance Registry System: 6-BROMO-5-METHOXY-2-PYRIDINECARBOXYLIC ACID(54232-43-8)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-37/39
• Hazardous Substances Data: 54232-43-8(Hazardous Substances Data)

Usage

Chemical Properties

White solid

InChI:InChI=1/C7H6BrNO3/c1-12-5-3-2-4(7(10)11)9-6(5)8/h2-3H,1H3,(H,10,11)

Upstream product

• 24207-22-5 2-bromo-3-methoxy-6-methyl-pyridine 
• 1121-78-4 5-Hydroxy-2-methylpyridine 
• 23003-35-2 2-bromo-3-hydroxy-6-methylpyridine 
• 29082-92-6 5-methoxypyridine-2-carboxylic acid 
• 672957-93-6 5-methoxypicolinic acid N-oxide 

Downstream Products

• 170235-18-4 methyl 2-bromo-3-methoxy-6-pyridinecarboxylic acid 
• 170235-19-5 methyl 2-bromo-3-hydroxy-6-pyridinecarboxylate 
• 178876-92-1 6-Bromo-5-hydroxy-pyridine-2-carboxylic acid 
• 1391846-44-8 (S)-3-[(6-bromo-5-methoxy-pyridine-2-carbonyl)-amino]-3-(2-chloro-phenyl)-propionic acid ethyl ester 
• 1415898-97-3 6-(3-Chlorophenyl)-5-methoxy-pyridine-2-carboxylic acid 
• 1610625-63-2 1-benzyloxy-2-oxo-3-[(carboxymethyl)oxy]-6-pyridinecarboxylic acid dimethyl ester 
• 1610625-64-3 1-benzyloxy-2-oxo-3-[(carboxymethyl)oxy]-6-pyridinecarboxylic acid 6-methyl ester 
• 1610625-65-4 N,N''-bis[1-benzyloxy-2-oxo-3-[(carboxyamidomethyl)oxy]-6-(methoxycarbonyl)pyridine]-N'-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-bis(2-aminoethyl)amine 
• 1610625-66-5 N,N''-bis[1-benzyloxy-2-oxo-3-[(carboxyamidomethyl)oxy]-6-carbonyl(2-mercaptothiazolide)pyridine]-N'-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-bis(2-aminoethyl)amine 

Relevant articles and documents

HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

The invention relates to a novel heterocyclic compound inhibiting a cyclin-dependent kinase (CDK) and a pharmaceutical composition comprising the same as an effective ingredient. The heterocyclic compound according to the present invention or pharmaceutically acceptable salt thereof can be effectively used in treating or preventing cancers, degenerative brain diseases, etc.

DI-MACROCYCLES

The invention relates to chemical compounds and complexes that can be used in therapeutic and diagnostic applications.

PYRIDIN- 2 -AMIDES USEFUL AS CB2 AGONISTS

The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.